1 week Ago By ABMN Staff
Oxford BioDynamics Plc ( LON:OBD – Get Free Report )’s stock price traded down 6.7% during trading on Thursday . The company traded as low as GBX 1.
30 ($0.02) and last traded at GBX 1.40 ($0.
02). 677,375 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 1,873,925 shares. The stock had previously closed at GBX 1.
50 ($0.02). Oxford BioDynamics Stock Performance The company has a debt-to-equity ratio of 370.
22, a current ratio of 0.68 and a quick ratio of 2.80.
The stock’s 50-day moving average is GBX 1.27 and its 200 day moving average is GBX 4.10.
The stock has a market cap of £3.74 million, a price-to-earnings ratio of -20.00 and a beta of 0.
42. Insider Activity In related news, insider David Holbrook purchased 49,653 shares of the stock in a transaction dated Monday, October 28th. The shares were acquired at an average cost of GBX 1 ($0.
01) per share, with a total value of £496.53 ($616.81).
Insiders own 16.78% of the company’s stock. Oxford BioDynamics Company Profile Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.
The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Further Reading Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter .
.
